monoclonal antibody

August 17, 2021

UAMS Now Providing COVID-19 Monoclonal Antibody Treatment in Northwest Arkansas

David Wise

Monoclonal Antibody Vial

FAYETTEVILLE – The University of Arkansas for Medical Sciences (UAMS) is now administering a special infusion to qualifying COVID-positive people in Northwest Arkansas to help minimize symptoms and keep people out of the hospital. UAMS is providing the subcutaneous monoclonal antibody injections (Regen-Cov) on its Fayetteville campus at 1125 N. College Ave. on Tuesday, Thursday and Friday…

February 20, 2018

Based on UAMS Research, InterveXion Wins Grants, Partners with BioVentures’ Help

Ben Boulden

Misty Stevens demonstrates one of the lab procedures InterveXion uses in the development of the monoclonal antibody it is studying for possible future use in the treatment of methamphetamine addiction.

Feb. 20, 2018 | Truly good ideas like the one around which InterveXion was built have staying power. Since InterveXion was established as a company in 2004, granting agencies and others have continued to value both the company and its mission. BioVentures from the first saw merit in the new treatment for methamphetamine abuse developed…

October 12, 2017

Researchers Awarded $8 Million for Anti-Methamphetamine Medication Study

Ben Boulden

Oct. 12, 2017 | Led by UAMS researchers, a new clinical study  called STAMPOUT aims to help a drug user stay in treatment by keeping the effects of the drug from going into the brain. This month, the National Institutes of Health (NIH) National Institute on Drug Abuse awarded the InterveXion/UAMS research team an $8…